Bionime Corporation (TPE:4737)
Taiwan · Delayed Price · Currency is TWD 65.60
+5.30 (8.79%)
Oct 30, 2026, 1:30 PM CST
Bionime Market Cap
Bionime has a market cap or net worth of 5.07 billion as of October 30, 2026. It is the 22,746th most valuable company in the world and the 1,119th biggest in Taiwan. Its market cap has increased by 19.27% in one year.
Market Cap
5.07B
Enterprise Value
7.35B
Revenue
1.72B
Global Rank
Country Rank
#1,119 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since September 3, 2009, Bionime's market cap has increased from 2.06B to 5.07B, an increase of 145.84%. That is a compound annual growth rate of 5.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 5.07B | 26.71% |
| Dec 31, 2025 | 4.00B | 1.37% |
| Dec 31, 2024 | 3.95B | -13.19% |
| Dec 29, 2023 | 4.55B | -2.90% |
| Dec 30, 2022 | 4.69B | 2.61% |
| Dec 30, 2021 | 4.57B | 12.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medeon Biodesign | 7.62B |
| Bioteque | 7.48B |
| Pacific Hospital Supply | 5.50B |
| Formosa Optical Technology | 5.35B |
| St.Shine Optical | 4.59B |
| ICARES Medicus | 3.63B |
| Maxigen Biotech | 3.26B |
| Nang Kuang Pharmaceutical | 3.11B |